vaccine therapy


Also found in: Encyclopedia.

vaccine therapy

A therapeutic strategy to boost the immune response against a particular pathogen to such degree that the vaccine alone is enough to treat the Pt

vaccine therapy

Injection of infectious organisms, particles, or antigens to produce active immunization against a disease. Synonym: opsonic therapy
References in periodicals archive ?
Prof Judith Swain, Executive Director of SICS said, "This excellent collaborative discovery between SICS and SIgN is a milestone in vaccine therapy for chronic infections.
tella has technology and know-how for the stable culture of high-quality DCs and other cells, and is providing its DC vaccine therapy as well as other technology and know-how for cancer treatment - which are based on technology developed by the Institute of Medical Science of the University of Tokyo - to 18 medical institutions throughout Japan, including national medical institutions and university hospitals.
Thus, combination of lamivudine and anti-HBV vaccine therapy did not have any effect on preventing viral resistance, which is one of the main problems during lamivudine therapy that limits the efficacy of the drug.
Prima and Prana will jointly share in the benefit of any intellectual property produced from the collaboration including milestone payments and royalties that may accrue as a consequence of producing a successful vaccine therapy.
Onyvax Ltd, London, UK, a leading vaccine therapy company, has completed patient recruitment in its Phase IIa clinical trial in prostate cancer.
Also called allergy vaccine therapy, this treatment consists of a series of injections given over time.
These trials will neither define the portion of atherosclerotic CVD caused by infection nor indicate benefits or risks of vaccine therapy.
He found out about the vaccine therapy as he surfed the internet examining research and the latest cancer treatments - and realised it might be able to help his 44-year-old wife.
We had poster presentations at the SITC 27th Annual Meeting(iv) held in the late October, on predictive markers for the efficacy of a breast cancer drug and dendritic cell vaccine therapy for cancers(v).
Of these, 16 of 16 patients with observation data had demonstrable CD4 and CD8+ T cell responses which, persisted after the completion of vaccine therapy.
These roles included Director Commercial Strategy Distribution Europe, Director European Vaccine Therapy Director Commercial Development UK, Director Vaccines Business Unit UK and Business Unit Manager Oncology UK.
Under the agreement, the two companies aim to develop a vaccine therapy for AD.

Full browser ?